Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gossamer Bio (GOSS) Change in Account Payables (2022 - 2025)

Gossamer Bio (GOSS) has 4 years of Change in Account Payables data on record, last reported at -$795000.0 in Q3 2025.

  • For Q3 2025, Change in Account Payables fell 169.49% year-over-year to -$795000.0; the TTM value through Sep 2025 reached -$4.5 million, down 847.05%, while the annual FY2024 figure was -$1.7 million, 141.5% down from the prior year.
  • Change in Account Payables reached -$795000.0 in Q3 2025 per GOSS's latest filing, up from -$5.8 million in the prior quarter.
  • Across five years, Change in Account Payables topped out at $4.3 million in Q4 2023 and bottomed at -$5.8 million in Q2 2025.
  • Average Change in Account Payables over 4 years is -$469866.7, with a median of -$795000.0 recorded in 2025.
  • Peak YoY movement for Change in Account Payables: surged 1395.44% in 2023, then plummeted 339.08% in 2024.
  • A 4-year view of Change in Account Payables shows it stood at $285000.0 in 2022, then soared by 1395.44% to $4.3 million in 2023, then dropped by 27.73% to $3.1 million in 2024, then plummeted by 125.81% to -$795000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Change in Account Payables were -$795000.0 in Q3 2025, -$5.8 million in Q2 2025, and -$937000.0 in Q1 2025.